L-Serine, N-[(2R,3R)-3-hydroxy-2,4-dimethyl-1-oxopentyl]-L-threonyl-D-alloisoleucyl-(2S)-2-(4-hydroxyphenyl)glycyl-N-methyl-L-phenylalanyl-D-allothreonyl-O-[N-[(2E)-3-[(2S)-2-[(1R)-1-hydroxyethyl]-2-oxiranyl]-1-oxo-2-propen-1-yl]glycyl]-, (6→13)-lactone, cyclic (1'→3)-ether
L-Serine, N-[(2R,3R)-3-hydroxy-2,4-dimethyl-1-oxopentyl]-L-threonyl-D-alloisoleucyl-(2S)-2-(4-hydroxyphenyl)glycyl-N-methyl-L-phenylalanyl-D-allothreonyl-O-[N-[(2E)-3-[(2S)-2-[(1R)-1-hydroxyethyl]-2-oxiranyl]-1-oxo-2-propen-1-yl]glycyl]-, (6→13)-lactone, cyclic (1'→3)-ether
CAS: 152340-22-2
Molecular Formula: C51H69N7O15
L-Serine, N-[(2R,3R)-3-hydroxy-2,4-dimethyl-1-oxopentyl]-L-threonyl-D-alloisoleucyl-(2S)-2-(4-hydroxyphenyl)glycyl-N-methyl-L-phenylalanyl-D-allothreonyl-O-[N-[(2E)-3-[(2S)-2-[(1R)-1-hydroxyethyl]-2-oxiranyl]-1-oxo-2-propen-1-yl]glycyl]-, (6→13)-lactone, cyclic (1'→3)-ether - Names and Identifiers
| Name | L-Serine, N-[(2R,3R)-3-hydroxy-2,4-dimethyl-1-oxopentyl]-L-threonyl-D-alloisoleucyl-(2S)-2-(4-hydroxyphenyl)glycyl-N-methyl-L-phenylalanyl-D-allothreonyl-O-[N-[(2E)-3-[(2S)-2-[(1R)-1-hydroxyethyl]-2-oxiranyl]-1-oxo-2-propen-1-yl]glycyl]-, (6→13)-lactone, cyclic (1'→3)-ether |
| Synonyms | L-Serine, N-[(2R,3R)-3-hydroxy-2,4-dimethyl-1-oxopentyl]-L-threonyl-D-alloisoleucyl-(2S)-2-(4-hydroxyphenyl)glycyl-N-methyl-L-phenylalanyl-D-allothreonyl-O-[N-[(2E)-3-[(2S)-2-[(1R)-1-hydroxyethyl]-2-oxiranyl]-1-oxo-2-propen-1-yl]glycyl]-, (6→13)-lactone, cyclic (1'→3)-ether Salinamide ADISCONTINUED Salinamide A (2R,3R)-N-{(1'S,2S,7'R,9'Z,17'S,20'S,21'S,29'S,32'R)-29'-benzyl-32'-[(1R)-1-hydroxyethyl]-7',20',28'-trimethyl-24'-[(1S)-1-methylpropyl]-11',14',18',22',25',27',30',33'-octaoxospiro[oxirane-2,8'-[6,15,19]trioxa[12,23,26,28,31,34]hexaazatricyclo[15.9.8.2~2 |
| CAS | 152340-22-2 |
L-Serine, N-[(2R,3R)-3-hydroxy-2,4-dimethyl-1-oxopentyl]-L-threonyl-D-alloisoleucyl-(2S)-2-(4-hydroxyphenyl)glycyl-N-methyl-L-phenylalanyl-D-allothreonyl-O-[N-[(2E)-3-[(2S)-2-[(1R)-1-hydroxyethyl]-2-oxiranyl]-1-oxo-2-propen-1-yl]glycyl]-, (6→13)-lactone, cyclic (1'→3)-ether - Physico-chemical Properties
| Molecular Formula | C51H69N7O15 |
| Molar Mass | 1020.15 |
| Density | 1.33±0.1 g/cm3(Predicted) |
| Boling Point | 1374.3±65.0 °C(Predicted) |
| pKa | 12.77±0.70(Predicted) |
![L-Serine, N-[(2R,3R)-3-hydroxy-2,4-dimethyl-1-oxopentyl]-L-threonyl-D-alloisoleucyl-(2S)-2-(4-hydroxyphenyl)glycyl-N-methyl-L-phenylalanyl-D-allothreonyl-O-[N-[(2E)-3-[(2S)-2-[(1R)-1-hydroxyethyl]-2-oxiranyl]-1-oxo-2-propen-1-yl]glycyl]-, (6→13)-lactone, cyclic (1'→3)-ether](http://res.chembk.com/assets/str/2d/1/15/152340-22-2.png)
Supplier List
View History
L-Serine, N-[(2R,3R)-3-hydroxy-2,4-dimethyl-1-oxopentyl]-L-threonyl-D-alloisoleucyl-(2S)-2-(4-hydroxyphenyl)glycyl-N-methyl-L-phenylalanyl-D-allothreonyl-O-[N-[(2E)-3-[(2S)-2-[(1R)-1-hydroxyethyl]-2-oxiranyl]-1-oxo-2-propen-1-yl]glycyl]-, (6→13)-lactone, cyclic (1'→3)-ether
2-{[1-(4-methanesulfonylphenyl)ethyl]amino}-2-methylpropan-1-ol
N-(5-CHLORO-2-PYRIMIDINYL)-2-THIOPHENECARBOXAMIDE
139432-69-2
4-Bromophenyl carbonochloridate
17626-02-7
74103-06-3
2-[3(S)-[3-[2-(7-Chloroquinoline-2-Yl)Ethenyl]Phenyl]-3-Hydroxypropyl]Benzene-2-Propanol
O-Cyclopropylmethyl-hydroxylamine, Hydrochloride
321-05-1
2-{[1-(4-methanesulfonylphenyl)ethyl]amino}-2-methylpropan-1-ol
N-(5-CHLORO-2-PYRIMIDINYL)-2-THIOPHENECARBOXAMIDE
139432-69-2
4-Bromophenyl carbonochloridate
17626-02-7
74103-06-3
2-[3(S)-[3-[2-(7-Chloroquinoline-2-Yl)Ethenyl]Phenyl]-3-Hydroxypropyl]Benzene-2-Propanol
O-Cyclopropylmethyl-hydroxylamine, Hydrochloride
321-05-1